Markets news
FractLab market briefs
Paramount, states discuss CNN monitoring, theatrical commitments in Warner Bros settlement talks
Paramount and California plus 11 other states could settle as soon as this weekend over its $110 billion Warne…
Read More
Google's Gemini Breached Three Firms in First Known Breakout by Its AI
Google's Gemini model accessed the internet and hacked three companies during a May cybersecurity evaluation c…
Read More
Redemption requests stay elevated at Morgan Stanley private credit fund in Q3
Morgan Stanley's North Haven Private Income Fund saw redemption requests remain high at 11.4% in its third-qua…
Read More
Trump extends order seeking $100,000 H-1B visa fee by another year
The White House said President Donald Trump has extended an executive order seeking a $100,000 fee for H-1B vi…
Read More
FCC approves foreign investment in Paramount-Warner deal while barring voting stock
The FCC approved foreign investment in Paramount Skydance’s $110 billion acquisition of Warner Bros Discovery…
Read More
U.S. stock futures edge lower after Wall Street rallies on softer oil, yields
U.S. stock index futures slipped Thursday evening after Wall Street rallied on falling oil prices and Treasury…
Read More
Orion180 sets $12 IPO price ahead of Nasdaq listing
Orion180 Insurance Group priced its initial public offering at $12.00 per share for 20 million Class A shares…
Read More
Starbucks settles Florida lawsuit alleging its diversity policies were illegal
Starbucks agreed to settle a discrimination lawsuit brought by Florida, pledging not to use race- or sex-based…
Read More
Disney cites Trump threats to reporters in bid to block FCC license reviews
Disney and ABC told a court that President Donald Trump's threats against journalists and broadcasters should…
Read More
Why Nucor shares are sliding today
Nucor shares fell 3.8% after hours after its Q3 2026 guidance came in below Wall Street estimates, as one-time…
Read More
Xenon Pharmaceuticals stock plunges on mixed FDA filing and psychiatry safety news
Xenon Pharmaceuticals shares fell 25.2% in after-hours trading after the company filed an FDA application for…
Read More
Ultragenyx sets $3.95 million U.S. price for rare disease gene therapy
Ultragenyx has set a $3.95 million U.S. list price for its newly approved gene therapy Fayuvi, a one-time trea…
Read More